Search Results - "NASS, Sharyl J"

Improving Cancer Diagnosis and Care: Patient Access to High‐Quality Oncologic Pathology by Nass, Sharyl J., Cohen, Michael B., Nayar, Ritu, Zutter, Mary M., Balogh, Erin P., Schilsky, Richard L., Hricak, Hedvig, Elenitoba‐Johnson, Kojo S.J.

“…Drawing on discussions at a workshop hosted by the National Cancer Policy Forum, current challenges in pathology are reviewed and practical steps to facilitate…”
Get full text

National Academies of Sciences, Engineering, and Medicine Standing Committee on Primary Care: An Objective Venue to Inform Policy by Meisnere, Marc, Nass, Sharyl J.

“…The 2021 National Academies of Sciences, Engineering, and Medicine (NASEM) report Implementing High-Quality Primary Care: Rebuilding the Foundation of Health…”
Get full text

Opening up to precompetitive collaboration by Altshuler, Jill S, Balogh, Erin, Barker, Anna D, Eck, Stephen L, Friend, Stephen H, Ginsburg, Geoffrey S, Herbst, Roy S, Nass, Sharyl J, Streeter, Christopher M, Wagner, John A

“…In order to enhance biomedical research and development efficiency and innovation, nontraditional research collaborations have emerged that feature the sharing…”
Get more information

Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy by Nass, Sharyl J., Nekhlyudov, Larissa

“…The increasing rate of contralateral prophylactic mastectomy (CPM) led the American Society of Breast Surgeons (ASBrS) to issue an evidence-based consensus…”
Get full text

Accelerating anticancer drug development — opportunities and trade-offs by Nass, Sharyl J., Rothenberg, Mace L., Pentz, Rebecca, Hricak, Hedvig, Abernethy, Amy, Anderson, Kenneth, Gee, Amanda Wagner, Harvey, R. Donald, Piantadosi, Steven, Bertagnolli, Monica M., Schrag, Deborah, Schilsky, Richard L.

“…The traditional approach to drug development in oncology, with discrete phases of clinical testing, is becoming untenable owing to expansion of the precision…”
Get full text

Patient‐Centered Cancer Treatment Planning: Improving the Quality of Oncology Care. Summary of an Institute of Medicine Workshop by Balogh, Erin P., Ganz, Patricia A., Murphy, Sharon B., Nass, Sharyl J., Ferrell, Betty R., Stovall, Ellen

“…The Institute of Medicine's National Cancer Policy Forum recently convened a workshop on patient‐centered cancer treatment planning, with the aim of raising…”
Get full text

Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise by Nass, Sharyl J, Cogle, Christopher R, Brink, James A, Langlotz, Curtis P, Balogh, Erin P, Muellner, Ada, Siegal, Dana, Schilsky, Richard L, Hricak, Hedvig

Get full text

Oncologic Errors in Diagnostic Radiology: A 10-Year Analysis Based on Medical Malpractice Claims by Rosenkrantz, Andrew B., Siegal, Dana, Skillings, Jillian A., Muellner, Ada, Nass, Sharyl J., Hricak, Hedvig

“…To retrospectively analyze the nature and extent of oncology-related errors accounting for malpractice allegations in diagnostic radiology. The Comparative…”
Get full text

Accelerating Cancer Therapy Development: The Importance of Combination Strategies and Collaboration. Summary of an Institute of Medicine Workshop by LORUSSO, Patricia M, CANETTA, Renzo, WAGNER, John A, BALOGH, Erin P, NASS, Sharyl J, BOERNER, Scott A, HOHNEKER, John

“…Cancer cells contain multiple genetic changes in cell signaling pathways that drive abnormal cell survival, proliferation, invasion, and metastasis…”
Get full text

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs by Balogh, Erin P., Bindman, Andrew B., Eckhardt, S. Gail, Halabi, Susan, Harvey, R. Donald, Jaiyesimi, Ishmael, Miksad, Rebecca, Moses, Harold L., Nass, Sharyl J., Schilsky, Richard L., Sun, Steven, Torrente, Josephine M., Warren, Katherine E.

“…A number of important drugs used to treat cancer—many of which serve as the backbone of modern chemotherapy regimens—have outdated prescribing information in…”
Get full text

Expanding Public‐Private Collaborations to Enhance Cancer Drug Development: A Report of the Institute of Medicine's Workshop Series, “Implementing a National Cancer Clinical Trials System for the 21st Century” by Bertagnolli, Monica M., Canetta, Renzo, Nass, Sharyl J.

“…Since their inception in the 1950s, the National Cancer Institute‐funded cancer cooperative groups have been important contributors to cancer clinical and…”
Get full text

National Trends in Oncologic Diagnostic Imaging by Rosenkrantz, Andrew B., Chaves Cerdas, Laura, Hughes, Danny R., Recht, Michael P., Nass, Sharyl J., Hricak, Hedvig

“…To characterize national trends in oncologic imaging (OI) utilization. This retrospective cross-sectional study used 2004 and 2016 CMS 5% Carrier Claims…”
Get full text

A National Cancer Clinical Trials Network: recommendations from the Institute of Medicine by Nass, Sharyl J, Balogh, Erin, Mendelsohn, John

“…Oncology has become one of the most active areas of drug discovery, with >800 cancer therapeutics in development. This not only presents an unprecedented…”
Get full text

Clinical Application of Computational Methods in Precision Oncology: A Review by Panagiotou, Orestis A, Högg, Lori Hoffman, Hricak, Hedvig, Khleif, Samir N, Levy, Mia A, Magnus, David, Murphy, Martin J, Patel, Bakul, Winn, Robert A, Nass, Sharyl J, Gatsonis, Constantine, Cogle, Christopher R

“…There is an enormous and growing amount of data available from individual cancer cases, which makes the work of clinical oncologists more demanding. This data…”
Get more information

Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop by Balogh, Erin P., Dresler, Carolyn, Fleury, Mark E., Gritz, Ellen R., Kean, Thomas J., Myers, Matthew L., Nass, Sharyl J., Nevidjon, Brenda, Toll, Benjamin A., Warren, Graham W., Herbst, Roy S.

“…Learning Objectives Describe strategies that clinicians can implement to reduce the burden of tobacco‐related cancers. Identify potential actions that could…”
Get full text

Identifying and Addressing the Needs of Adolescents and Young Adults With Cancer: Summary of an Institute of Medicine Workshop by Nass, Sharyl J., Beaupin, Lynda K., Demark‐Wahnefried, Wendy, Fasciano, Karen, Ganz, Patricia A., Hayes‐Lattin, Brandon, Hudson, Melissa M., Nevidjon, Brenda, Oeffinger, Kevin C., Rechis, Ruth, Richardson, Lisa C., Seibel, Nita L., Smith, Ashley W.

“…Cancer is the leading disease‐related cause of death in adolescents and young adults (AYAs). This population faces many short‐ and long‐term health and…”
Get full text

Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer by NASS, S. J, HERMAN, J. G, GABRIELSON, E, IVERSEN, P. W, PARL, F. F, DAVIDSON, N. E, GRAFF, J. R

“…Loss of expression for both the estrogen receptor-alpha and E-cadherin genes has been linked to disease progression in human ductal breast carcinomas and has…”
Get full text

Graduate Medical Education Outcomes and Metrics: Proceedings of a Workshop by Martin, Payal, Zindel, Mariana, Nass, Sharyl

“…Graduate medical education (GME) is critical to the career development of individual physicians, to the functioning of many teaching institutions, and to the…”
Get more information

Breast cancer biology blossoms in the clinic by Nass, Sharyl J, Hahm, Hillary A, Davidson, Nancy E

“…New clinical reports demonstrate that targeting the biological pathways of hormone and peptide growth factor receptors holds promise for the prevention and…”
Get full text

Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines by Yan, Lan, Nass, Sharyl J, Smith, Dawn, Nelson, William G, Herman, James G, Davidson, Nancy E

“…Recent studies have shown that changes in epigenetic regulation, such as DNA methylation and histone acetylation, are associated with silencing of the estrogen…”
Get full text